LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort

被引:30
作者
Bae, Ji Cheol [1 ]
Han, Ji Min [1 ]
Kwon, Sam [1 ]
Jee, Jae Hwan [2 ]
Yu, Tae Yang [3 ]
Lee, Moon Kyu [3 ]
Kim, Jae Hyeon [3 ,4 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Endocrinol & Metab,Dept Med, Chang Won 630723, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Hlth,Promot Ctr, Seoul 135710, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul 135710, South Korea
[4] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Clin Res Design & Evaluat, Seoul 135710, South Korea
关键词
Chronic kidney disease; Dyslipidemia; Estimated glomerular filtration rate; Triglycerides to high-density lipoprotein; cholesterol ratio; Low-density lipoprotein cholesterol; Apolipoprotein; PPAR-ALPHA AGONIST; INSULIN-RESISTANCE; RENAL DYSFUNCTION; LIPID-METABOLISM; PHENOTYPE-B; CHOLESTEROL; PROGRESSION; APOLIPOPROTEINS; ROSIGLITAZONE; NEPHROPATHY;
D O I
10.1016/j.atherosclerosis.2016.06.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: The objective of this study was to evaluate the ability of lipid variables to predict the development of chronic kidney disease (CKD). We investigated the longitudinal association between lipid profiles and incident CKD in a large apparently healthy cohort. Methods: A retrospective longitudinal analysis of 10,288 subjects who had participated in comprehensive health check-ups at least four times over a 7-year period was conducted. The risk of incident CKD associated with lipid variables was analyzed using adjusted hazard ratio (HR) for CKD per 1 standard deviation (SD) increase in lipid level. The development of CKD was defined as estimated glomerular filtration rate < 60 ml/min/1.73 m(2). Results: Over a mean follow-up of 56.5 +/- 14.3 months, 356 (3.5%) subjects developed CKD. The multivariate adjusted HRs for incident CKD per 1 SD increase in baseline lipid level were 1.29 (95% confidence interval [CI], 1.17-1.41) for triglycerides (TG), 0.77 (0.68-0.88) for high-density lipoprotein cholesterol (HDL-C), 1.22 (1.12-1.32) for the TG/HDL-C ratio, 0.82 (0.73-0.92) for the low-density lipoprotein cholesterol/apolipoprotein B (LDL-C/apoB) ratio, and 0.74 (0.66-0.83) for the HDL-C/apoA-1 ratio. No longitudinal association was found between incident CKD and baseline total cholesterol, LDL-C, non-HDL-C, the LDL-C/HDL-C ratio, apoB, apoA-I, or the apoB/apoA-I ratio. Conclusions: The LDL-C/apoB and HDL-C/apoA-1 ratios as well as TG and HDL-C concentrations independently predicted an increased risk for developing CKD. Our findings suggest that particle size of HDLs and LDLs may contribute to the development of CKD. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:170 / 176
页数:7
相关论文
共 41 条
[31]   Lipotoxicity: when tissues overeat [J].
Schaffer, JE .
CURRENT OPINION IN LIPIDOLOGY, 2003, 14 (03) :281-287
[32]   Advanced Lipoprotein Testing and Subfractionation Are Clinically Useful [J].
Superko, H. Robert .
CIRCULATION, 2009, 119 (17) :2383-2395
[33]   Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis [J].
Tanaka, Yuki ;
Kume, Shinji ;
Araki, Shin-ichi ;
Isshiki, Keiji ;
Chin-Kanasaki, Masami ;
Sakaguchi, Masayoshi ;
Sugimoto, Toshiro ;
Koya, Daisuke ;
Haneda, Masakazu ;
Kashiwagi, Atsunori ;
Maegawa, Hiroshi ;
Uzu, Takashi .
KIDNEY INTERNATIONAL, 2011, 79 (08) :871-882
[34]   Serum lipids and the progression of nephropathy in type 1 diabetes [J].
Thomas, MC ;
Rosengård-Bärlund, M ;
Mills, V ;
Rönnback, M ;
Thomas, S ;
Forsblom, C ;
Cooper, ME ;
Taskinen, MR ;
Viberti, G ;
Groop, PH .
DIABETES CARE, 2006, 29 (02) :317-322
[35]   Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes [J].
Tiikkainen, M ;
Häkkinen, AM ;
Korsheninnikova, E ;
Nyman, T ;
Mäkimattila, S ;
Yki-Järvinen, H .
DIABETES, 2004, 53 (08) :2169-2176
[36]   Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes [J].
Tolonen, N. ;
Forsblom, C. ;
Thorn, L. ;
Waden, J. ;
Rosengard-Barlund, M. ;
Saraheimo, M. ;
Feodoroff, M. ;
Makinen, V. -P. ;
Gordin, D. ;
Taskinen, M. -R. ;
Groop, P. -H. .
DIABETOLOGIA, 2009, 52 (12) :2522-2530
[37]  
Tsuruya K., 2015, AM J KIDNEY DIS OFF, V66
[38]   LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes [J].
Wägner, AM ;
Jorba, O ;
Rigla, M ;
Alonso, E ;
Ordóñez-Llanos, J ;
Pérez, A .
ACTA DIABETOLOGICA, 2002, 39 (04) :215-220
[39]   HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes [J].
Waldman, Boris ;
Jenkins, Alicia J. ;
Davis, Timothy M. E. ;
Taskinen, Marja-Riitta ;
Scott, Russell ;
O'Connell, Rachel L. ;
Gebski, Val J. ;
Ng, Martin K. C. ;
Keech, Anthony C. .
DIABETES CARE, 2014, 37 (08) :2351-2358
[40]   Lipotoxicity [J].
Weinberg, J. M. .
KIDNEY INTERNATIONAL, 2006, 70 (09) :1560-1566